Published in Medical Letter on the CDC and FDA, October 26th, 1998
Treatment history was found to be the most important factor contributing to the emergence of multidrug resistant disease.
Researchers from the Columbia Ministry of Health and the U.S. Centers for Disease Control and Prevention (CDC) conducted a study in an area of Columbia with an unusually high incidence of tuberculosis and found that inadequate retreatment of patients who were unresponsive to initial therapy and inappropriate additions and subtractions during therapy were critical in the rise of multidrug-resistant...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.